Literature DB >> 26846120

Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.

Zhihui Tian1, Jie Liu1, Mengyu Liao1, Wenjuan Li1, Jiaqi Zou1, Xinxin Han1, Mingjie Kuang1, Wanqiu Shen2, Haidong Li3.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is a chronic condition and the most common form of inflammatory bowel disease. The goal of standard treatment is mainly to induce and maintain remission with anti-inflammatory, immunosuppressive agents, and/or colectomy. Fecal microbiota transplantation (FMT) has been used successfully to treat relapsing or refractory Clostridium difficile infection. The alteration of microbiota in mouse models of UC as well as in patients suggested the possibility of treating UC with FMT. AIMS: To study the effects of FMT on dextran sodium sulfate (DSS)-induced UC model in mice.
METHODS: Littermates of BALB/c and C57BL/6J were randomized into four groups: normal control , treatment with DSS for 7 days (DSS - FMT), treatment with DSS followed by FMT for another 8 days (DSS + FMT), and treatment with DSS and FMT followed by another 5 days for recovery (remission). Body weight, survival rate, and DAI scores of mice in each group were recorded. Changes in distal colon were studied by histopathology. Alterations of spleen and lamina propria regulatory lymphocytes, major bacterial species in feces and inflammatory cytokines in colon were also studied.
RESULTS: C57BL/6J mice experienced more significant weight loss than BALB/c mice after DSS treatment, regardless of whether the two strains of mice were co-housed or not. FMT caused reversal of DAI scores in BALB/c but not in C57BL/6J mice. In BALB/c mice, FMT also reduced colon inflammation that was paralleled by decreased inflammatory cytokine levels, altered bacterial microbiota, and regulatory lymphocyte proportions.
CONCLUSIONS: FMT is effective in a mouse model of UC through its modulation on gut microbiota and the host immune system.

Entities:  

Keywords:  Fecal microbiota transplantation; Inflammatory cytokines; Mice; Ulcerative colitis

Mesh:

Substances:

Year:  2016        PMID: 26846120     DOI: 10.1007/s10620-016-4060-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  51 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The gut microbiota and inflammatory bowel disease.

Authors:  Yoshiyuki Goto; Yosuke Kurashima; Hiroshi Kiyono
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

3.  Intestinal bacterial colonization induces mutualistic regulatory T cell responses.

Authors:  Markus B Geuking; Julia Cahenzli; Melissa A E Lawson; Derek C K Ng; Emma Slack; Siegfried Hapfelmeier; Kathy D McCoy; Andrew J Macpherson
Journal:  Immunity       Date:  2011-05-19       Impact factor: 31.745

Review 4.  The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?

Authors:  Christopher J Damman; Samuel I Miller; Christina M Surawicz; Timothy L Zisman
Journal:  Am J Gastroenterol       Date:  2012-10       Impact factor: 10.864

Review 5.  Mucus layers in inflammatory bowel disease.

Authors:  Malin E V Johansson
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

6.  Patient perceptions of fecal microbiota transplantation for ulcerative colitis.

Authors:  Stacy A Kahn; Ashley Vachon; Dylan Rodriquez; Sarah R Goeppinger; Bonnie Surma; Julia Marks; David T Rubin
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

Review 7.  The genetics of Crohn's disease and ulcerative colitis--status quo and beyond.

Authors:  David Ellinghaus; Jörn Bethune; Britt-Sabina Petersen; Andre Franke
Journal:  Scand J Gastroenterol       Date:  2015-01       Impact factor: 2.423

Review 8.  The role of the microbiota in inflammation, carcinogenesis, and cancer therapy.

Authors:  Amiran Dzutsev; Romina S Goldszmid; Sophie Viaud; Laurence Zitvogel; Giorgio Trinchieri
Journal:  Eur J Immunol       Date:  2014-11-13       Impact factor: 5.532

Review 9.  Inflammatory bowel disease.

Authors:  Daniele Corridoni; Kristen O Arseneau; Fabio Cominelli
Journal:  Immunol Lett       Date:  2014-06-02       Impact factor: 3.685

10.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  30 in total

1.  Fecal Microbiota Transplantation for Ulcerative Colitis: FoMenTing Change?

Authors:  Flaviano S Martins
Journal:  Dig Dis Sci       Date:  2016-08       Impact factor: 3.199

Review 2.  Microbiota-based treatments in alcoholic liver disease.

Authors:  Hotaik Sung; Seung Woo Kim; Meegun Hong; Ki Tae Suk
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

3.  CRISPRs for Strain Tracking and Their Application to Microbiota Transplantation Data Analysis.

Authors:  Tony J Lam; Yuzhen Ye
Journal:  CRISPR J       Date:  2019-02-14

4.  Protective Effect of Prim-O-Glucosylcimifugin on Ulcerative Colitis and Its Mechanism.

Authors:  Yu Yin; Kunjian Liu; Guofeng Li
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

5.  Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice.

Authors:  Yefei Zhu; Yu Xu; Xinyue Wang; Leiping Rao; Xuebing Yan; Renyuan Gao; Tongyi Shen; Yuan Zhou; Cheng Kong; Longxiang Zhou
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

6.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

7.  Into the wild: microbiome transplant studies need broader ecological reality.

Authors:  Christopher J Greyson-Gaito; Timothy J Bartley; Karl Cottenie; Will M C Jarvis; Amy E M Newman; Mason R Stothart
Journal:  Proc Biol Sci       Date:  2020-02-26       Impact factor: 5.349

8.  Reproductive Senescence and Ischemic Stroke Remodel the Gut Microbiome and Modulate the Effects of Estrogen Treatment in Female Rats.

Authors:  Min Jung Park; Rachel Pilla; Aditya Panta; Sivani Pandey; Benjamin Sarawichitr; Jan Suchodolski; Farida Sohrabji
Journal:  Transl Stroke Res       Date:  2019-12-16       Impact factor: 6.829

9.  The gut microbiota contributes to the development of Staphylococcus aureus-induced mastitis in mice.

Authors:  Xiaoyu Hu; Jian Guo; Caijun Zhao; Peng Jiang; T Maimai; Li Yanyi; Yongguo Cao; Yunhe Fu; Naisheng Zhang
Journal:  ISME J       Date:  2020-04-27       Impact factor: 10.302

10.  Early-Life Intervention Using Exogenous Fecal Microbiota Alleviates Gut Injury and Reduce Inflammation Caused by Weaning Stress in Piglets.

Authors:  Xin Ma; Yuchen Zhang; Tingting Xu; Mengqi Qian; Zhiren Yang; Xiuan Zhan; Xinyan Han
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.